Clinical Trial Update: Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China [NA]

View source ↗

Summary

A clinical trial evaluating whether an Intelligent Lipid Management Decision-support System improves 1-year LDL-C target achievement in ischemic stroke or TIA p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Transient Ischemic Attack (TIA) | NA | Status: RECRUITING